Shriti Pharmaceutical Private Limited
About Shriti Pharmaceutical Private Limited
Data last updated:
Shriti Pharmaceutical Private Limited is a private limited company based in Khargone, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 August 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U33100MP2018PTC046419. Its GSTIN is 23AAJCR1027L1ZG (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3.61 Lakh. It was formerly known as Renken Pharmaceuticals Private Limited. It is led by directors including Sushil Badole and Rakesh Patidar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gangadham Colony Sanchiti Oil Mil Ke Samne, Khargone, Madhya Pradesh, India – 451001.
As per the financials filed for FY 2023, the company reported a revenue of ₹12.79 Lakh, a growth of 1% compared to the previous year. For the same year it recorded a net loss of ₹1.49 Lakh (net margin -11.7%) and EBITDA of -₹1.47 Lakh (EBITDA margin -11.5%). Revenue has grown at a compounded annual rate (CAGR) of 108% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressGangadham Colony Sanchiti Oil Mil Ke Samne, Khargone, Madhya Pradesh, India – 451001
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Shriti Pharmaceutical Private Limited
The main business activity of Shriti Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Shriti Pharmaceutical Private Limited FY 2025 filings available
Shriti Pharmaceutical Private Limited reported revenue of ₹12.79 Lakh (up 1% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Shriti Pharmaceutical Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 108% over three years, including 1% growth in the latest year. EBITDA fell 95% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Shriti Pharmaceutical Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹1.47 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.49 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Shriti Pharmaceutical Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -11.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -11.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Shriti Pharmaceutical are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Shriti Pharmaceutical Private Limited
Shriti Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| J S Provisions Private Limited | ₹12.8 Lakh (FY 2016) | •••• | •••• | 24.0% | •••• | New Delhi, Delhi, India |
| Cruze Fitness Private Limited | ₹12.8 Lakh (FY 2019) | •••• | •••• | -34.0% | •••• | New Delhi, Delhi, India |
| Unico Resources Private Limited | ₹12.79 Lakh (FY 2025) | •••• | •••• | -86.0% | •••• | Kolkata, West Bengal, India |
| Aatrey Exim Private Limited | ₹12.79 Lakh (FY 2019) | •••• | •••• | •••• | Nashik, Maharashtra, India | |
| Xtrails Expeditions Private Limited | ₹12.79 Lakh (FY 2024) | •••• | •••• | -50.0% | •••• | Bangalore, Karnataka, India |
| Shriti Pharmaceutical Private Limited this company | ₹12.79 Lakh (FY 2023) | •••• | •••• | 1.0% | •••• | Khargone, Madhya Pradesh, India |
| Shreebag Taluka Farmer Producer Company Limited | ₹12.79 Lakh (FY 2025) | •••• | •••• | -10.0% | •••• | Raigad, Maharashtra, India |
| Consolidated Shipping and Bulk Terminals Private Limited | ₹12.79 Lakh (FY 2025) | •••• | •••• | 6.0% | •••• | Hyderabad, Telangana, India |
| Mata Tuljai Trading Private Limited | ₹12.79 Lakh (FY 2024) | •••• | •••• | 15.0% | •••• | Nashik Road, Maharashtra, India |
| Macro Distributors Private Limited | ₹12.79 Lakh (FY 2016) | •••• | •••• | •••• | Kolkata, West Bengal, India | |
| Shyamli Kunj India Private Limited | ₹12.79 Lakh (FY 2025) | •••• | •••• | -1.0% | •••• | Patna, Bihar, India |
Peers are the five companies nearest above and the five nearest below Shriti Pharmaceutical by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Shriti Pharmaceutical Private Limited
Shriti Pharmaceutical has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sushil Badole Also directs: Samsh Meditech Management Private Limited | Director | 05 Dec 2019 | 6 Years 10 Months | Current |
| Rakesh Patidar Also directs: Samsh Meditech Management Private Limited | Director | 28 Aug 2018 | 8 Years 1 Months | Current |
| Rajeshwar Badole | Director | 09 Feb 2019 | 7 Years 8 Months | Current |
Ownership and Shareholding of Shriti Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Shriti Pharmaceutical Private Limited
Shriti Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Shriti Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Shriti Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Shriti Pharmaceutical Private Limited
Shriti Pharmaceutical Private Limited has 5 board changes on record since 2018: 3 appointments and 2 cessations. The latest: Rajeshwar Badole ceased to be Additional Director on 05 Dec 2019.
Credit Ratings, Litigation & Regulatory Alerts for Shriti Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Shriti Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Shriti Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Shriti Pharmaceutical Private Limited
Shriti Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAJCR1027L1ZG | Madhya Pradesh | Active | 11 Dec 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Shriti Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shriti Pharmaceutical Private Limited
Shriti Pharmaceutical is an active private limited company based in Khargone, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 August 2018 (8+ years old) and is registered under CIN U33100MP2018PTC046419.
Shriti Pharmaceutical reported revenue of ₹12.79 Lakh for FY 2023 (up 1% YoY).
Shriti Pharmaceutical has 3 current directors:
- Sushil Badole - Director
- Rakesh Patidar - Director
- Rajeshwar Badole - Director
Shriti Pharmaceutical reported a net loss of ₹1.49 Lakh (net margin -11.7%) and EBITDA of -₹1.47 Lakh (EBITDA margin -11.5%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Shriti Pharmaceutical is 108% over three years. In the latest year (FY 2023) revenue rose 1%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Shriti Pharmaceutical is 23AAJCR1027L1ZG, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Shriti Pharmaceutical is U33100MP2018PTC046419. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shriti Pharmaceutical was incorporated on 28 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Shriti Pharmaceutical by revenue are J S Provisions Private Limited, Cruze Fitness Private Limited, Unico Resources Private Limited, Aatrey Exim Private Limited, Xtrails Expeditions Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Rajeshwar Badole ceased to be Additional Director on 05 Dec 2019. Sushil Badole was appointed as Director on 05 Dec 2019. Arun ceased to be Director on 09 Feb 2019. Shriti Pharmaceutical has 5 board changes on record in total.
The registered office of Shriti Pharmaceutical is at Gangadham Colony Sanchiti Oil Mil Ke Samne, Khargone, Madhya Pradesh, India – 451001.